pfizer oral glp-1 discontinues receptor agonist danuglipron Pfizer announces the advancement of

Research suggests exercise improves weight maintenance and body composition during GLP-1 treatment, and in one study, a supervised exercise program allowed better maintenance of body weight and body composition one year after treatment termination

The platform is expected to launch in January 2026

The data overwhelmingly shows net cardiovascular benefit

Starting with one time and switching after 23 weeks if you experience intolerable nausea or appetite dysregulation is a standard, safe approach

At Prime Surgicare, your GLP-1 treatment is medically directed from consultation through long-term maintenance after your weight goals are achieved

Mild tenderness at the injection or IV site is possible